Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions

Inclusion Criteria: * Diminution of vision due to macular edema secondary to non-ischemic retinal vein occlusions, either central or branch * CMT ≥ 250 µ, * Willing to participate in the study. Exclusion Criteria: * Unwilling to participate in the study * Ischemic RVO * previous laser treatment * Glaucoma, macular ischemia, cataract, vitreous hemorrhage, and neovascularization of the iris * patients with previous anti VEGFs or steroid injections or any eye surgery three months before the inclusion * Cardiac co-morbidities result in significant hemodynamic changes * Respiratory diseases need treatment with antibiotics * Suffering from other chronic diseases as diabetes * Patient with allergy from triamcinolone acetonide.